HCG11 and exocrine pancreatic carcinoma: In conclusion, the pivotal observations in this study illustrated that HCG11 increased the expression of MDM2 via competitively targeting miR-579-3p to promote the Notch/Hes1 pathway, thereby promoting the progression of pancreatic carcinoma.